A Single Pathogen Inactivation System for Both Platelets and Plasma

The INTERCEPT Blood System™ is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. It is the first system available to treat both platelets and plasma, and simplifies processing by utilizing the same illumination device, process and active compound. This synergistic approach is designed to meet blood center requirements for efficiency, performance and compatibility with both whole blood and apheresis collections. More Test

 
INTERCEPT E-NEWSLETTER
INTERCEPT eNews delivers product news & information updates right to your inbox.
UNITED STATES RESIDENTS
This site is intended for use by healthcare professionals outside of the United States only. If you are a resident of the United States, please see important information HERE.
APPROVAL STATUS
The INTERCEPT Blood Systems for platelets and plasma are CE marked and produced to ISO 13485 Quality Standard.
Untitled Document